Therapeutic implications of low lymphocyte count in non-ST segment elevation acute coronary syndromes
- 1 December 2009
- journal article
- Published by Elsevier in European Journal of Internal Medicine
- Vol. 20 (8) , 768-774
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Regulatory T‐cell immunity and its relevance to atherosclerosisJournal of Internal Medicine, 2008
- Systematic Review: Comparing Routine and Selective Invasive Strategies for the Acute Coronary SyndromeAnnals of Internal Medicine, 2008
- Recurrent infarction causes the most deaths following myocardial infarction with left ventricular dysfunctionThe American Journal of Medicine, 2005
- Routine vs Selective Invasive Strategies in Patients With Acute Coronary SyndromesJAMA, 2005
- CD4 Cell Lymphopenia and Atherosclerosis in Renal Transplant RecipientsJournal of the American Society of Nephrology, 2003
- Early Circulating Lymphocyte Apoptosis in Human Septic Shock Is Associated with Poor OutcomeShock, 2002
- B-Lymphocyte Deficiency Increases Atherosclerosis in LDL Receptor–Null MiceArteriosclerosis, Thrombosis, and Vascular Biology, 2002
- Management of acute coronary syndromes. Variations in practice and outcome. Findings from the Global Registry of Acute Coronary Events (GRACE)European Heart Journal, 2002
- Incidence, determinants, and clinical course of reinfarction in-hospital after index acute myocardial infarction (results from the pooled data of the maximal individual therapy in acute myocardial infarction [mitra], and the myocardial infarction registry [MIR])The American Journal of Cardiology, 2001
- Predictors and long-term prognostic significance of recurrent infarction in the year after a first myocardial infarctionThe American Journal of Cardiology, 1993